^
BIOMARKER:

EGFR expression

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
EGFR expression
Lung Non-Small Cell Squamous Cancer
necitumumab
Sensitive
:
A1
EGFR expression
Colorectal Cancer
cetuximab
Sensitive
:
A1
EGFR expression
Chordoma
lapatinib
Sensitive
:
A2
EGFR expression
Non Small Cell Lung Cancer
erlotinib + ramucirumab
Sensitive
:
A2
EGFR expression
Non Small Cell Lung Cancer
erlotinib
Sensitive
:
B
EGFR expression
Colorectal Cancer
panitumumab
Sensitive
:
B
EGFR expression
HER2 Positive Breast Cancer
ado-trastuzumab emtansine
Sensitive
:
B
EGFR expression
Non Small Cell Lung Cancer
gefitinib
Sensitive
:
B
EGFR expression
Squamous Cell Carcinoma of Head and Neck
cetuximab
Sensitive
:
C1
EGFR expression
Non Small Cell Lung Cancer
durvalumab
Sensitive
:
C2
EGFR expression
Ovarian Cancer
gefitinib
Resistant
:
C2
EGFR expression
Solid Tumor
EGFR806-specific CAR T-cell therapy
Sensitive
:
C2
EGFR expression
Non Small Cell Lung Cancer
sintilimab
Sensitive
:
C3
EGFR expression
Non Small Cell Lung Cancer
PD-L1 inhibitor
Resistant
:
C3
EGFR expression
Pancreatic Adenocarcinoma
trastuzumab + erlotinib
Sensitive
:
C3
EGFR expression
Non Small Cell Lung Cancer
osimertinib
Sensitive
:
C3
EGFR expression
Lung Non-Squamous Non-Small Cell Cancer
gefitinib
Sensitive
:
C3
EGFR expression
Lung Adenocarcinoma
Tyrosine kinase inhibitor
Sensitive
:
C3
EGFR expression
Non Small Cell Lung Cancer
anlotinib + APL-502
Sensitive
:
C3
EGFR expression
Non Small Cell Lung Cancer
cetuximab + afatinib
Resistant
:
C3
EGFR expression
Triple Negative Breast Cancer
lapatinib
Sensitive
:
C3
EGFR expression
Nasopharyngeal Carcinoma
MRG003
Sensitive
:
C3
EGFR expression
Squamous Cell Carcinoma of Head and Neck
MRG003
Sensitive
:
C3
EGFR expression
Lung Adenocarcinoma
afatinib
Sensitive
:
C4
EGFR expression
Glioblastoma
paclitaxel
Sensitive
:
D
EGFR expression
Glioblastoma
selumetinib
Sensitive
:
D
EGFR expression
Glioma
gefitinib
Sensitive
:
D
EGFR expression
Squamous Cell Carcinoma of Head and Neck
vandetanib
Sensitive
:
D
EGFR expression
Pancreatic Cancer
afatinib
Sensitive
:
D
EGFR expression
Triple Negative Breast Cancer
AFM24
Sensitive
:
D
EGFR expression
Squamous Cell Carcinoma of Head and Neck
cetuximab + CYNK-101
Sensitive
:
D
EGFR expression
Non Small Cell Lung Cancer
cetuximab + CYNK-101
Sensitive
:
D